Edwards Lifesciences raises FY26 guidance following strong Q1
Edwards Lifesciences revealed that its Q1 2026 performance was better than expected, prompting it to uplift its previous FY26 outlook.
Edwards Lifesciences revealed that its Q1 2026 performance was better than expected, prompting it to uplift its previous FY26 outlook.
The National Healthtech Access Programme aims to improve accessibility to healthtech products across the NHS.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Medical Technology is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Intuitive Surgical expands platforms despite market headwind
The increased importance of safety for wearable devices
What does the EU Data Act mean for businesses?
GE HealthCare launches new ultrasound system for cardiovascular imaging